First human trial tests stem cell 'Nanoparticles' to repair scarred livers
NCT ID NCT07472270
Summary
This early-stage trial will test whether tiny particles from umbilical cord stem cells are safe for people with liver cirrhosis. Twelve adults with moderate liver scarring will receive increasing doses through an IV to check for side effects. Researchers will also look for early signs that these cell-free particles might help improve liver function and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, 100000, Vietnam
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.